Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oraxol vs IV Paclitaxel in Metastatic Breast Cancer
NCT02594371Phase 3Completed
- Sponsor
- Athenex
- Start
- Dec 2015
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of paclitaxel + encequidar in breast cancer, sponsored by Athenex. Started Dec 2015; status: completed.
02
Drugs
paclitaxel + encequidar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02594371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594371.